HekaBio Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Series B
  • (In Progress)

  • Latest Deal Amount
  • $20M

  • Investors
  • 6

HekaBio General Information

Description

Operator of an asset-light healthcare platform intended to offer radiation and other therapies for oncology and fibrotic disease and to invest in global healthcare technology. The company offers a broad category of development expertise in pharma, medical devices, in-vitro diagnostics, digital health, and cell and gene therapies, enabling researchers to advance a portfolio of breakthrough programs and provide patients with accelerated access to global healthcare innovations.

Contact Information

Website
www.heka.bio
Formerly Known As
Japan Neuroscience Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Chikiriya Tokyo Building, 8th Floor
  • 1-9-15 Nihonbashi Muromachi Chuo-ku
  • Tokyo, 103-0022
  • Japan
+81
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Chikiriya Tokyo Building, 8th Floor
  • 1-9-15 Nihonbashi Muromachi Chuo-ku
  • Tokyo, 103-0022
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HekaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) 10-Jul-2026 $20M In Progress Generating Revenue
8. Later Stage VC 16-Jun-2025 Completed Generating Revenue
7. Later Stage VC (Series B) 29-Jan-2021 Completed Generating Revenue
6. Early Stage VC (Series A) 23-Sep-2020 Completed Generating Revenue
5. Early Stage VC (Series A3) 31-Mar-2020 Completed Generating Revenue
4. Early Stage VC (Series A2) 31-Jul-2019 Completed Generating Revenue
3. Early Stage VC (Series A1) 07-Dec-2018 Completed Generating Revenue
2. Early Stage VC 30-Apr-2018 $3.01M $11M Completed Generating Revenue
1. Seed Round 01-Jan-2018 $8M $8M Completed Generating Revenue
To view HekaBio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

HekaBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an asset-light healthcare platform intended to offer radiation and other therapies for oncology and fibrotic
Biotechnology
Tokyo, Japan
21 As of 2026

Basel, Switzerland
 

Franklin Lakes, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HekaBio Competitors (10)

One of HekaBio’s 10 competitors is Roche, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Roche Corporation Basel, Switzerland
Becton, Dickinson and Company Corporation Franklin Lakes, NJ
Siemens Healthineers Corporation Forchheim, Germany
Cepheid Formerly VC-backed Sunnyvale, CA
Agilent Technologies Formerly PE-Backed Santa Clara, CA
You’re viewing 5 of 10 competitors. Get the full list »

HekaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HekaBio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alfresa Holdings Corporation Minority
Cosmo Public Relations Corporation Minority
Essential Pharma (Tokyo) Corporation Minority
Medifuture Corporation Minority
Ohara Pharmaceutical VC-Backed Company Minority
You’re viewing 5 of 6 investors. Get the full list »

HekaBio Investments & Acquisitions (6)

HekaBio’s most recent deal was a Later Stage VC with Vista (Decision/Risk Analysis) for . The deal was made on 01-Jul-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vista (Decision/Risk Analysis) 01-Jul-2023 Later Stage VC Decision/Risk Analysis
Limaca Medical 02-Jan-2023 Later Stage VC Diagnostic Equipment
AllMeD Solutions 01-Dec-2022 PIPE Therapeutic Devices
SalutarisMD 01-May-2021 Later Stage VC Surgical Devices
Alpha Tau Medical 13-Mar-2020 Early Stage VC Drug Discovery
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

HekaBio FAQs

  • When was HekaBio founded?

    HekaBio was founded in 2016.

  • Where is HekaBio headquartered?

    HekaBio is headquartered in Tokyo, Japan.

  • What is the size of HekaBio?

    HekaBio has 21 total employees.

  • What industry is HekaBio in?

    HekaBio’s primary industry is Biotechnology.

  • Is HekaBio a private or public company?

    HekaBio is a Private company.

  • What is HekaBio’s current revenue?

    The current revenue for HekaBio is .

  • How much funding has HekaBio raised over time?

    HekaBio has raised $23.7M.

  • Who are HekaBio’s investors?

    Alfresa Holdings, Cosmo Public Relations, Essential Pharma (Tokyo), Medifuture, and Ohara Pharmaceutical are 5 of 6 investors who have invested in HekaBio.

  • Who are HekaBio’s competitors?

    Roche, Becton, Dickinson and Company, Siemens Healthineers, Cepheid, and Agilent Technologies are some of the 10 competitors of HekaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process